KRAMPERA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 11.313
EU - Europa 10.187
AS - Asia 5.174
AF - Africa 69
SA - Sud America 68
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 18
Totale 26.863
Nazione #
US - Stati Uniti d'America 11.220
GB - Regno Unito 3.291
CN - Cina 3.072
SG - Singapore 1.379
IT - Italia 1.363
SE - Svezia 926
FR - Francia 889
RU - Federazione Russa 886
IE - Irlanda 865
DE - Germania 765
FI - Finlandia 668
UA - Ucraina 215
VN - Vietnam 132
JP - Giappone 101
BE - Belgio 99
KR - Corea 98
IN - India 74
CA - Canada 70
IR - Iran 66
ID - Indonesia 45
HK - Hong Kong 44
TR - Turchia 43
BR - Brasile 41
NL - Olanda 40
AU - Australia 32
AT - Austria 26
ES - Italia 26
TG - Togo 23
MY - Malesia 18
EG - Egitto 16
EU - Europa 16
MX - Messico 16
RO - Romania 16
CH - Svizzera 15
LT - Lituania 13
CL - Cile 12
PL - Polonia 12
IL - Israele 11
CM - Camerun 10
PK - Pakistan 9
PT - Portogallo 9
ZA - Sudafrica 9
AZ - Azerbaigian 8
BG - Bulgaria 8
IQ - Iraq 8
CZ - Repubblica Ceca 7
GR - Grecia 7
UZ - Uzbekistan 7
DK - Danimarca 6
KG - Kirghizistan 6
LV - Lettonia 6
NO - Norvegia 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
MA - Marocco 5
PA - Panama 5
SA - Arabia Saudita 5
TW - Taiwan 5
BD - Bangladesh 4
CO - Colombia 4
HU - Ungheria 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
AM - Armenia 3
CY - Cipro 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MV - Maldive 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
HR - Croazia 2
KH - Cambogia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TH - Thailandia 2
YE - Yemen 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PY - Paraguay 1
SM - San Marino 1
Totale 26.863
Città #
Southend 2.971
Jacksonville 1.958
Chandler 1.930
Woodbridge 1.225
Singapore 1.161
Ann Arbor 885
Dublin 858
Ashburn 738
Houston 664
Beijing 414
Jinan 323
Verona 322
Lawrence 314
Princeton 314
Wilmington 305
Shenyang 296
New York 261
Nanjing 260
Helsinki 152
Hebei 140
Sindelfingen 130
Tianjin 128
Milan 119
Zhengzhou 110
Changsha 99
Nanchang 97
Brussels 93
Haikou 90
Düsseldorf 85
Ningbo 85
Redmond 79
Hangzhou 76
Boardman 75
Guangzhou 72
Seoul 71
Dong Ket 70
Taiyuan 69
Taizhou 67
Jiaxing 65
Lancaster 59
Los Angeles 59
Seattle 57
Santa Clara 50
Moscow 49
Norwalk 46
Novosibirsk 44
Bologna 41
Jakarta 41
Rome 41
Auburn Hills 38
Fairfield 38
Kent 35
Lanzhou 35
Dallas 34
Hong Kong 34
Dearborn 31
Fuzhou 30
Redwood City 29
San Francisco 29
Toronto 28
Falls Church 27
Frankfurt am Main 24
Munich 24
Tokyo 24
Lomé 23
Tehran 23
Washington 23
Lappeenranta 21
Chicago 20
London 18
Vienna 18
Amsterdam 16
Madrid 16
Kuala Lumpur 13
Melbourne 13
Shenzhen 13
Zanjan 13
Paris 12
Xiangfen 12
Clearwater 11
Leawood 11
Parma 11
Cairo 10
Dongguan 10
Edinburgh 10
Florence 10
Kochi 10
Ottawa 10
Palermo 10
Perth 10
San Diego 10
Cambridge 9
Elora 9
Napoli 9
Nürnberg 9
Padova 9
Riva 9
Shanghai 9
Stockholm 9
Suwon 9
Totale 18.576
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 426
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog 277
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 270
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 196
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 186
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 171
Meninges: from protective membrane to stem cell niche 171
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues. 167
Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. 162
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 160
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 158
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 158
Quantitative fluorescence in situ hybridization on paraffin embedded tissue. 155
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 152
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 145
Domanda di brevetto per modello di utilità nr. TO2010U000026 depositata il 23 Febbraio 2010 dal titolo: "DISPOSITIVO PER LA COLTURA CELLULARE", poi convertito in brevetto modello nazionale (nr. 272134) ed internazionale (PCT/IB2011/000365). 143
IN VITRO CHARACTERIZATION OF THE DIFFERENTIATION OF MENINGEAL STEM/PRECURSOR CELLS INTO THE OLIGODENDROCYTE LINEAGE 142
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 141
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 140
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 138
In vitro characterization of the differentiation of meningeal Stem/precursor cells into the oligodendrocyte lineage 134
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 131
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 129
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood. 129
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 128
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 128
Migration of meningeal cells in response to contusive spinal cord injury 127
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 126
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 125
In vitro characterization of the differentiation of meningeal stem/precursor cells into the oligodendrocyte lineage 124
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. 122
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 121
Adipose derived mesenchimal stem cells and CNS: differentiation potential and immune suppression 121
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 121
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 121
Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment 120
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 119
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 117
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 117
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 116
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 116
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 115
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 113
Adipose-derived stromal cells (ASCs) 113
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 112
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 112
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 111
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies? 111
Effects of a Ceramic Biomaterial on Immune Modulatory Properties and Differentiation Potential of Human Mesenchymal Stromal Cells of Different Origin. 111
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 111
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 110
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 110
Meninges harbor cells expressing neural precursor markers during development and adulthood 110
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 110
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 110
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature 110
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 109
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 109
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 109
Acute Myeloid Leukemia (AML) after BMT in a patient with Acute T-Lymphoblastic Leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry 108
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 108
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 107
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice 107
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 107
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 106
A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 105
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 105
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 105
Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: a healing process mediated by adipose-derived adult stem cells (ASCs) 104
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 104
Adult spinal cord meninges: A new source of neural stem cells 104
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 103
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 102
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 101
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 101
Guided differentiation of MSCs for regeneration of perimplant bone 100
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-a. 99
Cytogenetic response to intensive chemotherapy in chronic myelogenous leukemia patients 99
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha 99
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 99
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 98
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 98
Sequential high dose chemotherapy with PBSC rescue in advanced hematologic malignancies 98
Immune Modulation by Mesenchymal Stem Cells 97
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE 97
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 96
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor gene function 95
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 95
Stem molecular signature of adipose-derived stromal cells. 95
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 95
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 95
Serum level of the soluble form of CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavourable outcome. 94
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 94
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 93
Impact of allogenic and autologous bone marrow transplantation on acute non-lymphoblastic leukemia treatment: a retrospective study 93
Serum- and stroma-free in vitro culture of primary B-CLL cells 93
Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment? 93
BMP-7 effects on osteogenic differentiation of mesenchymal stem cells 93
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients 92
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. 91
Totale 12.314
Categoria #
all - tutte 96.169
article - articoli 53.075
book - libri 0
conference - conferenze 41.082
curatela - curatele 0
other - altro 311
patent - brevetti 420
selected - selezionate 0
volume - volumi 1.281
Totale 192.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.508 0 0 0 0 0 0 167 267 207 324 140 403
2020/20212.945 208 426 191 387 339 351 47 218 203 32 358 185
2021/20222.615 304 707 38 175 120 54 31 154 102 92 234 604
2022/20235.503 405 565 509 1.047 455 1.336 30 327 569 47 133 80
2023/20243.038 110 211 257 303 339 502 191 175 33 207 475 235
2024/20253.166 440 493 360 1.202 364 277 30 0 0 0 0 0
Totale 27.252